411 - OPTIMIZING TREATMENT IN SECONDARY PREVENTION OF ASCVD, HOW TO CHOOSE FROM ALL THE AVAILABLE OPTIONS

Friday, October 28, 2022

1:30 PM – 1:50 PM EDT

Location: Canada Hall 2 East

Sponsored By

Target Audience: Community cardiologists, General: All cardiovascular (clinical and research) health professionals, Clinical cardiologists

Presenter(s)

Anil Gupta

Cardiologist
Trillium Health Partners
Mississauga, Ontario, Canada

Planning Committee Member(s)

FB

Francois Bujold

United States

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the challenges associated with polypharmacy in secondary prevention of ASCVD;
describe the conditions for a successful optimization of treatment in secondary prevention of ASCVD; and,
enumerate the benefits of treating inflammation in ASCVD patients.

Recent years brought many new therapies indicated in secondary prevention of CVD. With too many drugs to choose from we must optimize treatment in secondary prevention of ASCVD. This session has the objective to provide guidance on how to choose from all the available options.